Introduction
Cell adhesion, proliferation and differentiation in vivo is significantly controlled by the cells' local surrounding, the extracellular matrix (ECM), formed from a complex combination of proteins, glycoproteins, and proteoglycans. Hence implant-coating materials, mimicking ECM, are a promising research focus today. However, the especially well-known fibronectin-derived peptides (e.g., RGD, REDV) are not selective as they bind to integrins, present on many cell types. In this context, we investigated the establishment of an ECM-mimetic implant coating using genetically engineered elastin-like-proteins (ELP), whose cell-selectivity is adaptable by the integration of bioactive sequences.
Methods
The establishment of the ELP-based implant coating was exemplarily performed on Poly(L-lactide) (PLLA) as model implant material. Aiming at covalent attachment terminal amino groups were installed at the PLLA surface by means of various plasma-and wet-chemical treatments. Following immobilization of ELP was investigated using the bi-and trifunctional crosslinkers disuccinimidyle suberate (DSS) and tris(succinimidyle aminotriacetate) (TSAT) via different reaction processes with regard to coupling efficiency, determined by an adapted BCA-assay.
Results
Coupling efficiency of ELP seemed to be dependent on PLLA surface activation, the used crosslinker and the applied reaction process. Exemplarily the use of DSS yielded higher amounts of immobilized ELP compared to TSAT, probably due to the higher flexibility, yielding enhanced crosslinking and multilayer formation. As result optimized conditions for ELP immobilization regarding highest coupling efficiency could be defined and applied for sample preparation for a preliminary in vitro study, which evidenced enhanced human umbilical vein endothelial cell (HUVEC) proliferation compared to unmodified PLLA.
Conclusion
In summary, PLLA was successfully modified with ELP as ECM-mimetic implant coating. By the integration of bioactive sequences, functionality of implant surfaces can be tailored as shown at the example of enhanced HUVEC proliferation.
